Cann Group to focus on ‘production at scale’ as new CEO beds down by Steve Jones February 28, 2023April 30, 2024 Cann Group chief executive Peter Koetsier has spoken of his optimism for the future, insisting the […]
Cann Group revenue climbs 83% but losses deepen to A$18.8 million by Steve Jones February 24, 2023April 30, 2024
Company news: Cann Group; Hey Bud; Gamma Biomedical by Martin Lane and Steve Jones November 17, 2022April 29, 2024
We’ve put our money where our mouth is, says Cann Group as focus turns to generating revenue by Steve Jones November 11, 2022April 29, 2024
Cann Group looks to raise another A$10m for Mildura, puts Southern facility up for sale by Martin Lane October 25, 2022April 29, 2024
Avecho chief warns of placebo dangers as firms roll out CBD clinical trials by Steve Jones October 20, 2022April 29, 2024
Company news: Cann Group; Cronos; Releaf Group; Rua Bioscience; Incannex by Martin Lane October 12, 2022April 29, 2024
Modern medicine: can the dominance of oil and flower be challenged? by Steve Jones October 6, 2022April 29, 2024
